IP Library Granted Patent US 11,559,228
Granted Patent B2
US 11,559,228 · App. 15/807,486 · Granted Jan 24, 2023

Augmented and virtual reality eyewear, systems, and methods for delivering polarized light and determining glucose levels

Inventors: Nastasja U. Robaina (Coconut Grove, FL); Nicole Elizabeth Samec (Fort Lauderdale, FL); Mark Baerenrodt (Delray Beach, FL)
Assignee: Magic Leap, Inc.
A61B5/14558A61B5/0205A61B5/02055A61B5/145A61B5/1455A61B5/14532A61B5/4266A61B5/486A61B5/6803G06T19/006A61B5/024A61B5/0816
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,559,228
App. No.
15/807,486
Granted
Jan 24, 2023
Kind
B2
Abstract

Various embodiments of a user-wearable device can comprise a frame configured to mount on a user. The device can include a display attached to the frame and configured to direct virtual images to an eye of the user. The device can also include a light source configured to provide polarized light to the eye of the user and that the polarized light is configured to reflect from the eye of the user. The device can further include a light analyzer configured to determine a polarization angle rotation of the reflected light from the eye of the user such that a glucose level of the user can be determined based at least in part on the polarization angle rotation of the reflected light.

Claims (33)

1. A user-wearable device comprising:

a frame configured to mount on a user;

a display attached to the frame, the display configured to direct virtual images to an eye of the user and to transmit light from a surrounding environment to the eye of the user to allow a view of that surrounding environment;

a light source configured to provide polarized light to the eye of the user, wherein the polarized light is configured to reflect from the eye of the user;

one or more sensors configured to determine if the provided polarized light transmits to the iris of the user; and

a light analyzer configured to determine a polarization angle rotation of the reflected light from the eye of the user such that a glucose level of the user can be determined based at least in part on the polarization angle rotation of the reflected light,

wherein the light source comprises a polarization controller comprising at least one optical fiber and at least one piezo-electric actuator configured to apply pressure on the at least one optical fiber such that the optical fiber controls a polarization state of the polarized light provided to the eye of the user.

2. The user-wearable device of claim 1 , wherein the light source comprises a polarizing filter.

3. The user-wearable device of claim 1 , wherein the light source comprises a source of light having a wavelength in the range of 500 nm to 800 nm.

4. The user-wearable device of claim 1 ,

wherein the light analyzer comprises a rotatable filter.

5. The user-wearable device of claim 1 , further comprising processing electronics configured to determine the glucose level of the user based at least in part on the polarization angle rotation of the reflected light.

6. The user-wearable device of claim 5 , wherein the processing electronics is configured to determine a concentration of the glucose level based at least in part on the determined polarization angle rotation of the reflected light.

7. The user-wearable device of claim 5 , wherein the processing electronics is configured to determine the glucose level automatically for at least a period of time.

8. The user-wearable device of claim 7 , wherein the processing electronics is configured to:

determine whether to re-determine the glucose level; and

if determined, automatically re-determine the glucose level.

9. The user-wearable device of claim 5 , wherein the processing electronics is configured to remotely store and access the determined glucose level and/or information relating to the determined glucose level.

10. The user-wearable device of claim 9 , wherein the device is configured to track the glucose level of the user over time.

11. The user-wearable device of claim 10 , wherein the device is configured to compare a contemporaneous glucose level with a historical glucose level.

12. The user-wearable device of claim 11 , wherein the device is configured to provide an alert to the user or clinician in response to comparing the contemporaneous glucose level with the historical glucose level.

13. The user-wearable device of claim 1 , further comprising one or more sensors configured to detect at least one parameter relating to a physical state of the user.

14. The user-wearable device of claim 13 , wherein the at least one parameter comprises body temperature, skin temperature, heart rate, respiration rate, level of sweating, time elapsed since last meal, or time elapsed since last medication.

15. The user-wearable device of claim 13 , wherein the device is configured to analyze the determined glucose level based at least in part on the at least one parameter relating to the physical state of the user.

16. The user-wearable device of claim 13 , wherein the device is configured to provide an alert to the user or clinician when the at least one parameter falls outside a range.

17. The user-wearable device of claim 1 , further comprising an optical detector disposed with respect to the analyzer to detect the amount of polarized light reflected from the eye that passes through the analyzer.

18. The user-wearable device of claim 1 , further comprising one or more sensors configured to detect an activity or condition of the user.

19. The user-wearable device of claim 18 , wherein the activity comprises eating, taking medication, exercising, or a combination thereof.

20. The user-wearable device of claim 18 , wherein the device is configured to provide real time feedback relating to the activity or condition to the user.

21. The user-wearable device of claim 1 , wherein the device is configured to not determine the glucose level when the one or more sensors determine the polarized light did not transmit to the iris of the user.

22. The user-wearable device of claim 1 , wherein the one or more sensors comprise one or more eye-tracking sensors.

23. The user-wearable device of claim 1 , wherein the one or more sensors comprise one or more cameras.

24. The user-wearable device of claim 1 , wherein the at least one piezo-electric actuator is configured to apply pressure on the at least one optical fiber such that the optical fiber rotates the polarization state of the polarized light provided to the eye of the user.

Assignments (4)
SECURITY INTEREST Recorded Oct 15, 2025
From: MAGIC LEAP, INC.; MENTOR ACQUISITION ONE, LLC; MOLECULAR IMPRINTS, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 073109/0476 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2021
From: ROBAINA, NASTASJA U.; SAMEC, NICOLE ELIZABETH; BAERENRODT, MARK
To: MAGIC LEAP, INC.
Reel/Frame 055024/0050 →
ASSIGNMENT OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: JPMORGAN CHASE BANK, N.A.
To: CITIBANK, N.A.
Reel/Frame 050967/0138 →
PATENT SECURITY AGREEMENT Recorded Aug 22, 2019
From: MAGIC LEAP, INC.; MOLECULAR IMPRINTS, INC.; MENTOR ACQUISITION ONE, LLC
To: JP MORGAN CHASE BANK, N.A.
Reel/Frame 050138/0287 →
Cited By (1)
US 12,251,220